Royce & Associates’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,312
Closed -$1.6M 877
2024
Q1
$1.6M Sell
12,312
-23,666
-66% -$2.78M 0.01% 663
2023
Q4
$4.08M Sell
35,978
-25,118
-41% -$2.18M 0.04% 530
2023
Q3
$5.02M Sell
61,096
-27,087
-31% -$2.38M 0.05% 475
2023
Q2
$8.27M Sell
88,183
-58,690
-40% -$4.69M 0.08% 360
2023
Q1
$9.98M Sell
146,873
-2,620
-2% -$212K 0.1% 310
2022
Q4
$10.6M Buy
149,493
+6,241
+4% +$425K 0.11% 272
2022
Q3
$8.9M Buy
143,252
+20,813
+17% +$1.5M 0.1% 294
2022
Q2
$8.18M Sell
122,439
-87,935
-42% -$6.61M 0.08% 338
2022
Q1
$15.1M Sell
210,374
-34,000
-14% -$2.78M 0.13% 231
2021
Q4
$23.4M Sell
244,374
-79,650
-25% -$5.39M 0.17% 162
2021
Q3
$15.8M Buy
324,024
+181,024
+127% +$9.1M 0.12% 277
2021
Q2
$7.19M Buy
143,000
+118,100
+474% +$5.81M 0.05% 520
2021
Q1
$976K Buy
+24,900
New +$968K 0.01% 855

Other funds holding BXC

Royce & Associates's BXC Position: Q2 2024 in Review

Royce & Associates sold out of BlueLinx (BXC) in Q2 2024, closing a stake of 12,312 shares — an estimated $1.6M sold.

Royce & Associates first reported a position in BXC in Q1 2021 and held it in 13 quarters. The position peaked at $23.4M in Q4 2021. 168 funds tracked by Wall St. Rank hold BXC as of Q2 2024.

  • Royce & Associates reported no remaining BlueLinx position as of Q2 2024 after selling out during the quarter.
  • Royce & Associates sold 12,312 BlueLinx shares in Q2 2024, an estimated $1.6M.
  • Royce & Associates first reported a position in BlueLinx in Q1 2021 and held it in 13 quarters.
  • Royce & Associates's BlueLinx position peaked at $23.4M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held BlueLinx as of Q2 2024.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.